Daniel R Principe, Patrick W Underwood, Sandeep Kumar, Kaytlin E Timbers, Regina M Koch, Jose G Trevino, Hidayatullah G Munshi, Ajay Rana. Front Oncol 2022
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.
Daniel R Principe, Rui Xiong, Yangfeng Li, Thao N D Pham, Suneel D Kamath, Oleksii Dubrovskyi, Kiira Ratia, Fei Huang, Jiong Zhao, Zhengnan Shen,[...]. Proc Natl Acad Sci U S A 2022
Daniel R Principe, Rui Xiong, Yangfeng Li, Thao N D Pham, Suneel D Kamath, Oleksii Dubrovskyi, Kiira Ratia, Fei Huang, Jiong Zhao, Zhengnan Shen,[...]. Proc Natl Acad Sci U S A 2022
100
Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy.
Daniel R Principe, Matthew Narbutis, Sandeep Kumar, Alex Park, Navin Viswakarma, Matthew J Dorman, Suneel D Kamath, Paul J Grippo, Melissa L Fishel, Rosa F Hwang,[...]. Cancer Res 2020
Daniel R Principe, Matthew Narbutis, Sandeep Kumar, Alex Park, Navin Viswakarma, Matthew J Dorman, Suneel D Kamath, Paul J Grippo, Melissa L Fishel, Rosa F Hwang,[...]. Cancer Res 2020
100
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.
Andrea Wang-Gillam, Richard A Hubner, Jens T Siveke, Daniel D Von Hoff, Bruce Belanger, Floris A de Jong, Beloo Mirakhur, Li-Tzong Chen. Eur J Cancer 2019
Andrea Wang-Gillam, Richard A Hubner, Jens T Siveke, Daniel D Von Hoff, Bruce Belanger, Floris A de Jong, Beloo Mirakhur, Li-Tzong Chen. Eur J Cancer 2019
50
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.
Davendra P S Sohal, Pamela B Mangu, Daniel Laheru. J Oncol Pract 2017
Davendra P S Sohal, Pamela B Mangu, Daniel Laheru. J Oncol Pract 2017
50
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.
Daniel R Principe, Patrick W Underwood, Murray Korc, Jose G Trevino, Hidayatullah G Munshi, Ajay Rana. Front Oncol 2021
Daniel R Principe, Patrick W Underwood, Murray Korc, Jose G Trevino, Hidayatullah G Munshi, Ajay Rana. Front Oncol 2021
50
Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort.
Daniel R Principe, Matthew Narbutis, Regina Koch, Ajay Rana. Sci Rep 2020
Daniel R Principe, Matthew Narbutis, Regina Koch, Ajay Rana. Sci Rep 2020
50
TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer.
Daniel R Principe, Alex Park, Matthew J Dorman, Sandeep Kumar, Navin Viswakarma, Jonathan Rubin, Carolina Torres, Ronald McKinney, Hidayatullah G Munshi, Paul J Grippo,[...]. Mol Cancer Ther 2019
Daniel R Principe, Alex Park, Matthew J Dorman, Sandeep Kumar, Navin Viswakarma, Jonathan Rubin, Carolina Torres, Ronald McKinney, Hidayatullah G Munshi, Paul J Grippo,[...]. Mol Cancer Ther 2019
50
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
50
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.
Andrew J Wilson, Matthew Stubbs, Phillip Liu, Bruce Ruggeri, Dineo Khabele. Gynecol Oncol 2018
Andrew J Wilson, Matthew Stubbs, Phillip Liu, Bruce Ruggeri, Dineo Khabele. Gynecol Oncol 2018
25
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.
Diar Aziz, Neil Portman, Kristine J Fernandez, Christine Lee, Sarah Alexandrou, Alba Llop-Guevara, Zoe Phan, Aliza Yong, Ashleigh Wilkinson, C Marcelo Sergio,[...]. NPJ Breast Cancer 2021
Diar Aziz, Neil Portman, Kristine J Fernandez, Christine Lee, Sarah Alexandrou, Alba Llop-Guevara, Zoe Phan, Aliza Yong, Ashleigh Wilkinson, C Marcelo Sergio,[...]. NPJ Breast Cancer 2021
25
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Hessmann, Steven A Johnsen, Jens T Siveke, Volker Ellenrieder. Gut 2017
Elisabeth Hessmann, Steven A Johnsen, Jens T Siveke, Volker Ellenrieder. Gut 2017
25
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, Michaela Ihle, Stephanie Hampp, Dietrich Alexander Ruess, Elisabeth Hessmann, Ronan Russell, André Lechel, Ninel Azoitei,[...]. Cancer Res 2017
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, Michaela Ihle, Stephanie Hampp, Dietrich Alexander Ruess, Elisabeth Hessmann, Ronan Russell, André Lechel, Ninel Azoitei,[...]. Cancer Res 2017
25
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.
Yi Du, Hirohito Yamaguchi, Yongkun Wei, Jennifer L Hsu, Hung-Ling Wang, Yi-Hsin Hsu, Wan-Chi Lin, Wen-Hsuan Yu, Paul G Leonard, Gilbert R Lee,[...]. Nat Med 2016
Yi Du, Hirohito Yamaguchi, Yongkun Wei, Jennifer L Hsu, Hung-Ling Wang, Yi-Hsin Hsu, Wan-Chi Lin, Wen-Hsuan Yu, Paul G Leonard, Gilbert R Lee,[...]. Nat Med 2016
25
Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
Robert R McWilliams, Kari G Rabe, Curtis Olswold, Mariza De Andrade, Gloria M Petersen. Cancer 2005
Robert R McWilliams, Kari G Rabe, Curtis Olswold, Mariza De Andrade, Gloria M Petersen. Cancer 2005
25
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, Laura L Fernandes, Shenghui Tang, Hisani N Horne, Jinzhong Liu, Chao Liu, Sarah J Schrieber, Jingyu Yu,[...]. Clin Cancer Res 2017
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, Laura L Fernandes, Shenghui Tang, Hisani N Horne, Jinzhong Liu, Chao Liu, Sarah J Schrieber, Jingyu Yu,[...]. Clin Cancer Res 2017
25
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.
Jason P W Carey, Cansu Karakas, Tuyen Bui, Xian Chen, Smruthi Vijayaraghavan, Yang Zhao, Jing Wang, Keith Mikule, Jennifer K Litton, Kelly K Hunt,[...]. Cancer Res 2018
Jason P W Carey, Cansu Karakas, Tuyen Bui, Xian Chen, Smruthi Vijayaraghavan, Yang Zhao, Jing Wang, Keith Mikule, Jennifer K Litton, Kelly K Hunt,[...]. Cancer Res 2018
25
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
25
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
Panagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, Monica Mita, John W Moroney, Robert Holloway, Linda Van Le, Jasgit C Sachdev, Eloise Chapman-Davis, Gerardo Colon-Otero,[...]. JAMA Oncol 2019
Panagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, Monica Mita, John W Moroney, Robert Holloway, Linda Van Le, Jasgit C Sachdev, Eloise Chapman-Davis, Gerardo Colon-Otero,[...]. JAMA Oncol 2019
25
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Stephanie A Yazinski, Valentine Comaills, Rémi Buisson, Marie-Michelle Genois, Hai Dang Nguyen, Chu Kwen Ho, Tanya Todorova Kwan, Robert Morris, Sam Lauffer, André Nussenzweig,[...]. Genes Dev 2017
Stephanie A Yazinski, Valentine Comaills, Rémi Buisson, Marie-Michelle Genois, Hai Dang Nguyen, Chu Kwen Ho, Tanya Todorova Kwan, Robert Morris, Sam Lauffer, André Nussenzweig,[...]. Genes Dev 2017
25
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis.
Raffaella Casolino, Salvatore Paiella, Danila Azzolina, Philip A Beer, Vincenzo Corbo, Giulia Lorenzoni, Dario Gregori, Talia Golan, Chiara Braconi, Fieke E M Froeling,[...]. J Clin Oncol 2021
Raffaella Casolino, Salvatore Paiella, Danila Azzolina, Philip A Beer, Vincenzo Corbo, Giulia Lorenzoni, Dario Gregori, Talia Golan, Chiara Braconi, Fieke E M Froeling,[...]. J Clin Oncol 2021
25
Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells.
Aki Miyasaka, Katsutoshi Oda, Yuji Ikeda, Osamu Wada-Hiraike, Tomoko Kashiyama, Atsushi Enomoto, Noriko Hosoya, Takahiro Koso, Tomohiko Fukuda, Kanako Inaba,[...]. BMC Cancer 2014
Aki Miyasaka, Katsutoshi Oda, Yuji Ikeda, Osamu Wada-Hiraike, Tomoko Kashiyama, Atsushi Enomoto, Noriko Hosoya, Takahiro Koso, Tomohiko Fukuda, Kanako Inaba,[...]. BMC Cancer 2014
25
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Jake E Delmore, Ghayas C Issa, Madeleine E Lemieux, Peter B Rahl, Junwei Shi, Hannah M Jacobs, Efstathios Kastritis, Timothy Gilpatrick, Ronald M Paranal, Jun Qi,[...]. Cell 2011
Jake E Delmore, Ghayas C Issa, Madeleine E Lemieux, Peter B Rahl, Junwei Shi, Hannah M Jacobs, Efstathios Kastritis, Timothy Gilpatrick, Ronald M Paranal, Jun Qi,[...]. Cell 2011
25
Population-Based Genetic Testing for BRCA1 and BRCA2.
Steven Narod, Mohammad R Akbari. J Clin Oncol 2018
Steven Narod, Mohammad R Akbari. J Clin Oncol 2018
25
Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer.
Ning Zhang, Yu-Nan Tian, Li-Na Zhou, Meng-Zhu Li, Hua-Dong Chen, Shan-Shan Song, Xia-Juan Huan, Xu-Bin Bao, Ao Zhang, Ze-Hong Miao,[...]. Cell Death Dis 2021
Ning Zhang, Yu-Nan Tian, Li-Na Zhou, Meng-Zhu Li, Hua-Dong Chen, Shan-Shan Song, Xia-Juan Huan, Xu-Bin Bao, Ao Zhang, Ze-Hong Miao,[...]. Cell Death Dis 2021
25
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Joyce F Liu, Sara M Tolaney, Michael Birrer, Gini F Fleming, Mary K Buss, Suzanne E Dahlberg, Hang Lee, Christin Whalen, Karin Tyburski, Eric Winer,[...]. Eur J Cancer 2013
Joyce F Liu, Sara M Tolaney, Michael Birrer, Gini F Fleming, Mary K Buss, Suzanne E Dahlberg, Hang Lee, Christin Whalen, Karin Tyburski, Eric Winer,[...]. Eur J Cancer 2013
25
Spatially restricted loading of BRD2 at DNA double-strand breaks protects H4 acetylation domains and promotes DNA repair.
Ozge Gursoy-Yuzugullu, Chelsea Carman, Brendan D Price. Sci Rep 2017
Ozge Gursoy-Yuzugullu, Chelsea Carman, Brendan D Price. Sci Rep 2017
25
The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinoma.
Gordon T Moffat, Eileen M O'Reilly. Clin Adv Hematol Oncol 2020
Gordon T Moffat, Eileen M O'Reilly. Clin Adv Hematol Oncol 2020
25
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
Martin F Lavin. Nat Rev Mol Cell Biol 2008
Martin F Lavin. Nat Rev Mol Cell Biol 2008
25
PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.
Michael Fraser, Helen Zhao, Kaisa R Luoto, Cecilia Lundin, Carla Coackley, Norman Chan, Anthony M Joshua, Tarek A Bismar, Andrew Evans, Thomas Helleday,[...]. Clin Cancer Res 2012
Michael Fraser, Helen Zhao, Kaisa R Luoto, Cecilia Lundin, Carla Coackley, Norman Chan, Anthony M Joshua, Tarek A Bismar, Andrew Evans, Thomas Helleday,[...]. Clin Cancer Res 2012
25
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Nicholas Pulliam, Fang Fang, Ali R Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B Baylin, Daniela Matei, Harikrishna Nakshatri,[...]. Clin Cancer Res 2018
Nicholas Pulliam, Fang Fang, Ali R Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B Baylin, Daniela Matei, Harikrishna Nakshatri,[...]. Clin Cancer Res 2018
25
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy. Front Oncol 2018
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy. Front Oncol 2018
25
A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery.
Kenichi Iwai, Tadahiro Nambu, Yukie Kashima, Jie Yu, Kurt Eng, Kazumasa Miyamoto, Kazuyo Kakoi, Masamitsu Gotou, Toshiyuki Takeuchi, Akifumi Kogame,[...]. Sci Adv 2021
Kenichi Iwai, Tadahiro Nambu, Yukie Kashima, Jie Yu, Kurt Eng, Kazumasa Miyamoto, Kazuyo Kakoi, Masamitsu Gotou, Toshiyuki Takeuchi, Akifumi Kogame,[...]. Sci Adv 2021
50
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.
Jian-Fang Ning, Monica Stanciu, Melissa R Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L Martuza, Hiroaki Wakimoto,[...]. Nat Commun 2019
Jian-Fang Ning, Monica Stanciu, Melissa R Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L Martuza, Hiroaki Wakimoto,[...]. Nat Commun 2019
25
Selective inhibition of BET bromodomains.
Panagis Filippakopoulos, Jun Qi, Sarah Picaud, Yao Shen, William B Smith, Oleg Fedorov, Elizabeth M Morse, Tracey Keates, Tyler T Hickman, Ildiko Felletar,[...]. Nature 2010
Panagis Filippakopoulos, Jun Qi, Sarah Picaud, Yao Shen, William B Smith, Oleg Fedorov, Elizabeth M Morse, Tracey Keates, Tyler T Hickman, Ildiko Felletar,[...]. Nature 2010
25
DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation.
Rachel Abbotts, Michael J Topper, Christopher Biondi, Daniel Fontaine, Reena Goswami, Lora Stojanovic, Eun Yong Choi, Lena McLaughlin, Aksinija A Kogan, Limin Xia,[...]. Proc Natl Acad Sci U S A 2019
Rachel Abbotts, Michael J Topper, Christopher Biondi, Daniel Fontaine, Reena Goswami, Lora Stojanovic, Eun Yong Choi, Lena McLaughlin, Aksinija A Kogan, Limin Xia,[...]. Proc Natl Acad Sci U S A 2019
25
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen,[...]. J Natl Cancer Inst 2018
Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen,[...]. J Natl Cancer Inst 2018
25
PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Michał Mikuła, Jerzy Ostrowski, Agnieszka Śliwińska, Aneta Rogalska. Int J Mol Sci 2020
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Michał Mikuła, Jerzy Ostrowski, Agnieszka Śliwińska, Aneta Rogalska. Int J Mol Sci 2020
25
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial.
Teresa Macarulla, Jean-Frédéric Blanc, Andrea Wang-Gillam, Li-Tzong Chen, Jens T Siveke, Beloo Mirakhur, Jie Chen, Floris A de Jong. J Geriatr Oncol 2019
Teresa Macarulla, Jean-Frédéric Blanc, Andrea Wang-Gillam, Li-Tzong Chen, Jens T Siveke, Beloo Mirakhur, Jie Chen, Floris A de Jong. J Geriatr Oncol 2019
25
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
25
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination.
Shanthi Adimoolam, Mint Sirisawad, Jun Chen, Patti Thiemann, James M Ford, Joseph J Buggy. Proc Natl Acad Sci U S A 2007
Shanthi Adimoolam, Mint Sirisawad, Jun Chen, Patti Thiemann, James M Ford, Joseph J Buggy. Proc Natl Acad Sci U S A 2007
25
25
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.
Bernard Friedenson. MedGenMed 2005
Bernard Friedenson. MedGenMed 2005
25
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
25
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.
Michael J Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J Hwang, Brandon G Smaglo, Sunnie S Kim, Benjamin A Weinberg, Louis M Weiner, John L Marshall, Jonathan R Brody. Clin Cancer Res 2020
Michael J Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J Hwang, Brandon G Smaglo, Sunnie S Kim, Benjamin A Weinberg, Louis M Weiner, John L Marshall, Jonathan R Brody. Clin Cancer Res 2020
25
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.
Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Srividya Bhaskara, Leandro Cerchietti, Santhana G T Devaraj, Bhavin Shah, Sunil Sharma, Jenny C Chang, Ari M Melnick,[...]. Oncotarget 2014
Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Srividya Bhaskara, Leandro Cerchietti, Santhana G T Devaraj, Bhavin Shah, Sunil Sharma, Jenny C Chang, Ari M Melnick,[...]. Oncotarget 2014
25
Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1.
Yu Pan, Qinglin Fei, Ping Xiong, Jianyang Yang, Zheyang Zhang, Xianchao Lin, Minggui Pan, Fengchun Lu, Heguang Huang. Oncoimmunology 2019
Yu Pan, Qinglin Fei, Ping Xiong, Jianyang Yang, Zheyang Zhang, Xianchao Lin, Minggui Pan, Fengchun Lu, Heguang Huang. Oncoimmunology 2019
25
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Diana Zatreanu, Helen M R Robinson, Omar Alkhatib, Marie Boursier, Harry Finch, Lerin Geo, Diego Grande, Vera Grinkevich, Robert A Heald, Sophie Langdon,[...]. Nat Commun 2021
Diana Zatreanu, Helen M R Robinson, Omar Alkhatib, Marie Boursier, Harry Finch, Lerin Geo, Diego Grande, Vera Grinkevich, Robert A Heald, Sophie Langdon,[...]. Nat Commun 2021
25
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.
Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.